COMP <GO>
EPC vs AMZN // ENTERPRISE SCALE & MARKET CAP
Edgewell Personal Care Company (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: EPC 4
— AMZN 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: AMZN
LAST: $28.57 (0.00%) • MKT CAP: $1.32B
market-cap
$1.32B
LAST: $240.35 (-1.41%) • MKT CAP: $2.63T
market-cap
$2.63T
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EPC VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EPC | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.50% | 17.61% | -15.11 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.4x | 15.8x | +13.65 | AMZN | /valuation <GO> |
| Free Cash Flow Yield | 8.99% | -1.81% | +10.80 | EPC | /fcf-yield <GO> |
| Operating Margin | 4.30% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 1.10% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -1.30% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.23% | 0.00% | +2.23 | EPC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.58 | 3.32 | -1.74 | AMZN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | EPC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.73% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 47.2 | +8.40 | EPC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.46 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 48.2x | 21.7x | +26.52 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $1.32B | $2.63T | -$2.63T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EPC REV | AMZN REV | EPC GROSS % | AMZN GROSS % | EPC FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $2.22B | $0 | 41.6% | — | $118.4M | $10.56B |
| FY 2024 | $2.25B | $0 | 42.4% | — | -$231.0M | $42.95B |
| FY 2023 | $2.25B | $0 | — | — | -$216.1M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EPC // BETA —
AMZN // BETA 1.46